These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4067601)

  • 1. d-Amphetamine raises cortisol levels in schizophrenic patients with and without chronic naltrexone pretreatment.
    van Kammen DP; Schulz SC
    J Neural Transm; 1985; 64(1):35-43. PubMed ID: 4067601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence.
    Jayaram-Lindström N; Konstenius M; Eksborg S; Beck O; Hammarberg A; Franck J
    Neuropsychopharmacology; 2008 Jul; 33(8):1856-63. PubMed ID: 17957221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats.
    Todtenkopf MS; O'Neill KS; Kriksciukaite K; Turncliff RZ; Dean RL; Ostrovsky-Day I; Deaver DR
    Addict Biol; 2009 Sep; 14(4):408-18. PubMed ID: 19489752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextroamphetamine and cortisol in depression. Morning plasma cortisol levels suppressed.
    Sachar EJ; Asnis G; Nathan RS; Halbreich U; Tabrizi MA; Halpern FS
    Arch Gen Psychiatry; 1980 Jul; 37(7):755-7. PubMed ID: 7190380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortisol and GH responses to D- and L-amphetamine in monkeys.
    Marantz R; Sachar EJ; Weitzman E; Sassin J
    Endocrinology; 1976 Aug; 99(2):459-65. PubMed ID: 954645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of d- and l-fenfluramine (and their interactions with d-amphetamine) on cortisol secretion.
    Feeney S; Goodall E; Silverstone T
    Int Clin Psychopharmacol; 1993; 8(3):139-42. PubMed ID: 8263310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia.
    Rao ML; Strebel B; Halaris A; Gross G; Bräunig P; Huber G; Marler M
    Psychiatry Res; 1995 Jun; 57(1):21-39. PubMed ID: 7568556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic d-amphetamine inhibits opioid receptor antagonist-induced supersensitivity.
    Duttaroy A; Billings B; Candido J; Yoburn BC
    Eur J Pharmacol; 1992 Oct; 221(2-3):211-5. PubMed ID: 1330622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers.
    Grady TA; Broocks A; Canter SK; Pigott TA; Dubbert B; Hill JL; Murphy DL
    Psychiatry Res; 1996 Aug; 64(1):1-10. PubMed ID: 8888359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of plasma beta-endorphin immunoreactivity to d-amphetamine and placebo in schizophrenic patients.
    Schulz SC; van Kammen DP; Pickar D; Cohen MR; Naber D
    Psychiatry Res; 1982 Oct; 7(2):171-8. PubMed ID: 6292981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hydrocortisone administration does not affect subjective responses to d-amphetamine in humans.
    Wachtel SR; Charnot A; de Wit H
    Psychopharmacology (Berl); 2001 Jan; 153(3):380-8. PubMed ID: 11271411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple, single-dose naltrexone administrations fail to effect overall cognitive functioning and plasma cortisol in individuals with probable Alzheimer's disease.
    Pomara N; Roberts R; Rhiew HB; Stanley M; Gershon S
    Neurobiol Aging; 1985; 6(3):233-6. PubMed ID: 3903533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine and electroencephalographic sleep changes due to acute amphetamine ingestion in human beings.
    Valerde C; Pastrana LS; Ruiz JA; Solís H; Jurado JL; Sordo CM; Fernández-Guardiola A; Maisterrena JA
    Neuroendocrinology; 1976; 22(1):57-71. PubMed ID: 1030786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. d-amphetamine inhibition of platelet MAO from schizophrenic patients.
    Reches A; Ebstein RP; Belmaker RH
    Biol Psychiatry; 1977 Oct; 12(5):655-9. PubMed ID: 412527
    [No Abstract]   [Full Text] [Related]  

  • 15. Riluzole and D-amphetamine interactions in humans.
    Sofuoglu M; Waters AJ; Mooney M; Kosten T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):16-22. PubMed ID: 17714844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study.
    Strajhar P; Vizeli P; Patt M; Dolder PC; Kratschmar DV; Liechti ME; Odermatt A
    J Steroid Biochem Mol Biol; 2019 Feb; 186():212-225. PubMed ID: 30381248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Melatonin and schizophrenia].
    Fanget F; Claustrat B; Dalery J; Brun J; Terra JL; Marie-Cardine M; Guyotat J
    Encephale; 1989; 15(6):505-10. PubMed ID: 2575517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamine response to methamphetamine is related to glucocorticoid levels but not to pleasurable subjective response.
    Harris DS; Reus VI; Wolkowitz O; Jacob P; Everhart ET; Wilson M; Mendelson JE; Jones RT
    Pharmacopsychiatry; 2006 May; 39(3):100-8. PubMed ID: 16721698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
    Dougherty GG; Ellinwood EH
    Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of acute d-amphetamine effects on thyrotropin release.
    Little KY; Garbutt JC; Mayo JP; Mason G
    Neuroendocrinology; 1988 Sep; 48(3):304-7. PubMed ID: 3141826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.